Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.34)
# 1,092
Out of 4,412 analysts
348
Total ratings
33.33%
Success rate
6.81%
Average return
Main Sectors:
44 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCS Oculis Holding AG | Maintains: Buy | $29 → $28 | $12.02 | +132.95% | 5 | Apr 24, 2024 | |
| ASLN ASLAN Pharmaceuticals | Reiterates: Buy | $9 | $0.42 | +2,067.11% | 16 | Apr 23, 2024 | |
| BRNS Barinthus Biotherapeutics | Reiterates: Buy | $8 | $2.50 | +220.00% | 4 | Apr 22, 2024 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $16 | $4.75 | +237.20% | 15 | Apr 19, 2024 | |
| ICCM IceCure Medical | Reiterates: Buy | $3 | $1.20 | +150.00% | 12 | Apr 16, 2024 | |
| GNPX Genprex | Reiterates: Buy | $10 | $2.21 | +352.49% | 3 | Apr 4, 2024 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | $22 → $21 | $6.30 | +233.33% | 15 | Apr 2, 2024 | |
| KPRX Kiora Pharmaceuticals | Maintains: Buy | $2 | $0.47 | +325.53% | 11 | Mar 27, 2024 | |
| FWBI First Wave BioPharma | Reinstates: Neutral | n/a | $2.74 | - | 12 | Mar 25, 2024 | |
| BLTE Belite Bio | Maintains: Buy | $59 | $39.75 | +48.43% | 12 | Mar 22, 2024 | |
| OKYO OKYO Pharma | Maintains: Buy | $6 → $7 | $1.47 | +376.16% | 4 | Mar 22, 2024 | |
| ANIX Anixa Biosciences | Reiterates: Buy | $12 | $3.23 | +271.52% | 13 | Mar 21, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | $48 | $15.68 | +206.12% | 1 | Mar 20, 2024 | |
| CODX Co-Diagnostics | Maintains: Neutral | $3 → $2.5 | $1.11 | +125.23% | 12 | Mar 15, 2024 | |
| CLSD Clearside Biomedical | Reiterates: Buy | $6 | $1.34 | +347.76% | 13 | Mar 14, 2024 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $2.41 | +274.22% | 9 | Mar 12, 2024 | |
| LFMD LifeMD | Reiterates: Buy | $12 | $11.95 | +0.42% | 5 | Mar 12, 2024 | |
| RGNX REGENXBIO | Initiates: Buy | $36 | $16.19 | +122.36% | 1 | Mar 11, 2024 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 | $16.75 | +97.01% | 15 | Mar 8, 2024 | |
| ALIM Alimera Sciences | Maintains: Buy | $5 → $6 | $3.49 | +71.92% | 13 | Mar 8, 2024 | |
| MYNZ Mainz Biomed B.V. | Maintains: Buy | $5 → $3 | $0.82 | +266.70% | 9 | Mar 6, 2024 | |
| ZYXI Zynex | Maintains: Buy | $20 → $21 | $11.21 | +87.33% | 11 | Mar 1, 2024 | |
| OPK OPKO Health | Reiterates: Buy | $3 | $1.26 | +138.10% | 6 | Feb 28, 2024 | |
| GLSI Greenwich LifeSciences | Reiterates: Buy | $36 | $13.12 | +174.39% | 4 | Feb 28, 2024 | |
| PRPH ProPhase Labs | Reiterates: Buy | $11 | $4.71 | +133.55% | 14 | Feb 21, 2024 | |
| APDN Applied DNA Sciences | Maintains: Buy | $2 → $1.5 | $4.37 | -65.68% | 16 | Feb 9, 2024 | |
| VERU Veru Inc. | Reiterates: Buy | $2 | $1.27 | +57.48% | 14 | Feb 8, 2024 | |
| ANGO AngioDynamics | Maintains: Buy | $20 → $18 | $5.81 | +209.81% | 3 | Jan 8, 2024 | |
| SRTS Sensus Healthcare | Reiterates: Buy | $8 | $3.41 | +134.60% | 11 | Nov 13, 2023 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $22 → $21 | $14.79 | +41.99% | 10 | Oct 6, 2023 | |
| MOTS Motus GI Holdings | Reiterates: Buy | $38 | $0.08 | +46,196.30% | 9 | Sep 27, 2023 | |
| NMRD Nemaura Medical | Maintains: Buy | $7 → $2.5 | $0.05 | +4,512.55% | 4 | Aug 21, 2023 | |
| OPGN OpGen | Downgrades: Neutral | n/a | $0.51 | - | 6 | Aug 14, 2023 | |
| CDNA CareDx | Reiterates: Neutral | n/a | $7.56 | - | 2 | Aug 9, 2023 | |
| RNLX Renalytix | Reiterates: Buy | $5 | $0.63 | +695.17% | 8 | Jun 30, 2023 | |
| CNTG Centogene | Reiterates: Buy | $1.5 | $0.49 | +206.81% | 8 | Jun 28, 2023 | |
| CHEK Check-Cap | Downgrades: Neutral | n/a | $2.29 | - | 5 | Jun 7, 2023 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $240 → $180 | $2.68 | +6,616.42% | 1 | May 19, 2022 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $58 → $48 | $30.57 | +57.02% | 5 | Apr 22, 2022 | |
| IDXG Interpace Biosciences | Downgrades: Neutral | n/a | $1.50 | - | 4 | Nov 17, 2021 | |
| EYEN Eyenovia | Maintains: Buy | n/a | $0.63 | - | 2 | Apr 1, 2021 | |
| CELC Celcuity | Maintains: Buy | n/a | $15.92 | - | 2 | Feb 17, 2021 | |
| CYDY CytoDyn | Reiterates: Buy | n/a | $0.14 | - | 2 | Apr 28, 2020 | |
| OGEN Oragenics | Downgrades: Neutral | n/a | $1.03 | - | 1 | Apr 16, 2020 |
Oculis Holding AG
Apr 24, 2024
Maintains: Buy
Price Target: $29 → $28
Current: $12.02
Upside: +132.95%
ASLAN Pharmaceuticals
Apr 23, 2024
Reiterates: Buy
Price Target: $9
Current: $0.42
Upside: +2,067.11%
Barinthus Biotherapeutics
Apr 22, 2024
Reiterates: Buy
Price Target: $8
Current: $2.50
Upside: +220.00%
Ocular Therapeutix
Apr 19, 2024
Reiterates: Buy
Price Target: $16
Current: $4.75
Upside: +237.20%
IceCure Medical
Apr 16, 2024
Reiterates: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Genprex
Apr 4, 2024
Reiterates: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Kala Pharmaceuticals
Apr 2, 2024
Maintains: Buy
Price Target: $22 → $21
Current: $6.30
Upside: +233.33%
Kiora Pharmaceuticals
Mar 27, 2024
Maintains: Buy
Price Target: $2
Current: $0.47
Upside: +325.53%
First Wave BioPharma
Mar 25, 2024
Reinstates: Neutral
Price Target: n/a
Current: $2.74
Upside: -
Belite Bio
Mar 22, 2024
Maintains: Buy
Price Target: $59
Current: $39.75
Upside: +48.43%
OKYO Pharma
Mar 22, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $1.47
Upside: +376.16%
Anixa Biosciences
Mar 21, 2024
Reiterates: Buy
Price Target: $12
Current: $3.23
Upside: +271.52%
Tourmaline Bio
Mar 20, 2024
Reiterates: Buy
Price Target: $48
Current: $15.68
Upside: +206.12%
Co-Diagnostics
Mar 15, 2024
Maintains: Neutral
Price Target: $3 → $2.5
Current: $1.11
Upside: +125.23%
Clearside Biomedical
Mar 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.34
Upside: +347.76%
Alpha Tau Medical
Mar 12, 2024
Reiterates: Buy
Price Target: $9
Current: $2.41
Upside: +274.22%
LifeMD
Mar 12, 2024
Reiterates: Buy
Price Target: $12
Current: $11.95
Upside: +0.42%
REGENXBIO
Mar 11, 2024
Initiates: Buy
Price Target: $36
Current: $16.19
Upside: +122.36%
EyePoint Pharmaceuticals
Mar 8, 2024
Maintains: Buy
Price Target: $33
Current: $16.75
Upside: +97.01%
Alimera Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $3.49
Upside: +71.92%
Mainz Biomed B.V.
Mar 6, 2024
Maintains: Buy
Price Target: $5 → $3
Current: $0.82
Upside: +266.70%
Zynex
Mar 1, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $11.21
Upside: +87.33%
OPKO Health
Feb 28, 2024
Reiterates: Buy
Price Target: $3
Current: $1.26
Upside: +138.10%
Greenwich LifeSciences
Feb 28, 2024
Reiterates: Buy
Price Target: $36
Current: $13.12
Upside: +174.39%
ProPhase Labs
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $4.71
Upside: +133.55%
Applied DNA Sciences
Feb 9, 2024
Maintains: Buy
Price Target: $2 → $1.5
Current: $4.37
Upside: -65.68%
Veru Inc.
Feb 8, 2024
Reiterates: Buy
Price Target: $2
Current: $1.27
Upside: +57.48%
AngioDynamics
Jan 8, 2024
Maintains: Buy
Price Target: $20 → $18
Current: $5.81
Upside: +209.81%
Sensus Healthcare
Nov 13, 2023
Reiterates: Buy
Price Target: $8
Current: $3.41
Upside: +134.60%
Bausch + Lomb
Oct 6, 2023
Reiterates: Buy
Price Target: $22 → $21
Current: $14.79
Upside: +41.99%
Motus GI Holdings
Sep 27, 2023
Reiterates: Buy
Price Target: $38
Current: $0.08
Upside: +46,196.30%
Nemaura Medical
Aug 21, 2023
Maintains: Buy
Price Target: $7 → $2.5
Current: $0.05
Upside: +4,512.55%
OpGen
Aug 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.51
Upside: -
CareDx
Aug 9, 2023
Reiterates: Neutral
Price Target: n/a
Current: $7.56
Upside: -
Renalytix
Jun 30, 2023
Reiterates: Buy
Price Target: $5
Current: $0.63
Upside: +695.17%
Centogene
Jun 28, 2023
Reiterates: Buy
Price Target: $1.5
Current: $0.49
Upside: +206.81%
Check-Cap
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.29
Upside: -
Bio-Path Holdings
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $2.68
Upside: +6,616.42%
DENTSPLY SIRONA
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $30.57
Upside: +57.02%
Interpace Biosciences
Nov 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Eyenovia
Apr 1, 2021
Maintains: Buy
Price Target: n/a
Current: $0.63
Upside: -
Celcuity
Feb 17, 2021
Maintains: Buy
Price Target: n/a
Current: $15.92
Upside: -
CytoDyn
Apr 28, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.14
Upside: -
Oragenics
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.03
Upside: -